Phase I clinical trial of donor T-helper type-2 cells after immunoablative, reduced intensity allogeneic PBSC transplant

Cytotherapy. 2002;4(5):429-30. doi: 10.1080/146532402320776053.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I

MeSH terms

  • CD4-Positive T-Lymphocytes / immunology
  • Graft vs Host Disease
  • Humans
  • Lymphoma, Non-Hodgkin / therapy
  • Peripheral Blood Stem Cell Transplantation*
  • Stem Cell Transplantation / methods*
  • Th2 Cells / transplantation*
  • Time Factors